145 related articles for article (PubMed ID: 8048200)
21. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
[TBL] [Abstract][Full Text] [Related]
22. FDG PET for detection and therapy control of metastatic germ cell tumor.
Cremerius U; Effert PJ; Adam G; Sabri O; Zimmy M; Wagenknecht G; Jakse G; Buell U
J Nucl Med; 1998 May; 39(5):815-22. PubMed ID: 9591582
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
24. Routine X-ray of the chest is not justified in staging of cutaneous melanoma patients.
Gjørup CA; Hendel HW; Pilegaard RK; Willert CB; Hölmich LR
Dan Med J; 2016 Dec; 63(12):. PubMed ID: 27910800
[TBL] [Abstract][Full Text] [Related]
25. Is there an indication for routine chest X-ray in initial staging of melanoma?
Vermeeren L; van der Ent FW; Hulsewé KW
J Surg Res; 2011 Mar; 166(1):114-9. PubMed ID: 19691983
[TBL] [Abstract][Full Text] [Related]
26. Follow-up of clinical stage I testicular cancer patients: cost and risk benefit considerations.
Kakehi Y; Kamoto T; Kawakita M; Ogawa O
Int J Urol; 2002 Mar; 9(3):154-60; discussion 160-1. PubMed ID: 12010325
[TBL] [Abstract][Full Text] [Related]
27. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
28. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria.
Hilton S; Herr HW; Teitcher JB; Begg CB; Castéllino RA
AJR Am J Roentgenol; 1997 Aug; 169(2):521-5. PubMed ID: 9242768
[TBL] [Abstract][Full Text] [Related]
29. Chest X-ray sensitivity and lung cancer outcomes: a retrospective observational study.
Bradley SH; Bhartia BS; Callister ME; Hamilton WT; Hatton NLF; Kennedy MP; Mounce LT; Shinkins B; Wheatstone P; Neal RD
Br J Gen Pract; 2021 Nov; 71(712):e862-e868. PubMed ID: 33875450
[TBL] [Abstract][Full Text] [Related]
30. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management.
Shahidi M; Norman AR; Dearnaley DP; Nicholls J; Horwich A; Huddart RA
Cancer; 2002 Aug; 95(3):520-30. PubMed ID: 12209744
[TBL] [Abstract][Full Text] [Related]
31. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.
Leibovitch L; Foster RS; Kopecky KK; Donohue JP
J Urol; 1995 Nov; 154(5):1759-63. PubMed ID: 7563341
[TBL] [Abstract][Full Text] [Related]
32. Chest radiography versus chest CT in the evaluation for pulmonary metastases in patients with Wilms' tumor: a retrospective review.
Wootton-Gorges SL; Albano EA; Riggs JM; Ihrke H; Rumack CM; Strain JD
Pediatr Radiol; 2000 Aug; 30(8):533-7; discussion 537-9. PubMed ID: 10993537
[TBL] [Abstract][Full Text] [Related]
33. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
34. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors.
Spermon JR; Roeleveld TA; van der Poel HG; Hulsbergen-van de Kaa CA; Ten Bokkel Huinink WW; van de Vijver M; Witjes JA; Horenblas S
Urology; 2002 Jun; 59(6):923-9. PubMed ID: 12031382
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
[TBL] [Abstract][Full Text] [Related]
36. Neural network analysis of quantitative histological factors to predict pathological stage in clinical stage I nonseminomatous testicular cancer.
Moul JW; Snow PB; Fernandez EB; Maher PD; Sesterhenn IA
J Urol; 1995 May; 153(5):1674-7. PubMed ID: 7715008
[TBL] [Abstract][Full Text] [Related]
37. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.
Puglisi F; Follador A; Minisini AM; Cardellino GG; Russo S; Andreetta C; Di Terlizzi S; Piga A
Ann Oncol; 2005 Feb; 16(2):263-6. PubMed ID: 15668281
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors.
Tsatalpas P; Beuthien-Baumann B; Kropp J; Manseck A; Tiepolt C; Hakenberg OW; Burchert W; Franke WG; Wirth MP
Urol Int; 2002; 68(3):157-63. PubMed ID: 11919460
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of clinical and histopathologic diagnosis for early stages of advanced nonseminomatous germ cell testicular tumors].
Sosnowski M; Płuzańska A; Chmielowski M; Dowgier-Witczak I; Jeromir L
Pol Merkur Lekarski; 1997 Apr; 2(10):273-6. PubMed ID: 9377665
[TBL] [Abstract][Full Text] [Related]
40. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
